|
|
See Category: Diseases of the digestive system
See Header: Ulcerative colitis, unspecified, with complications
ICD-10 (CM) Code and Descriptor
|
K51.919 |
Ulcerative colitis, unspecified with unspecified complications
|
K51919 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 50.39%
|
16.78%
|
9.47%
|
7.06%
|
4.86%
|
3.44%
|
2.41%
|
1.60%
|
1.04%
|
0.93%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for K51.919*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,832
|
1,832
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,801
|
1,806
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,637
|
1,637
|
|
J3380
|
INJ VEDOLIZUMAB IV 1 MG |
1,563
|
470,100
|
|
96413
|
CHEMO IV INFUSION 1 HR |
1,499
|
1,499
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
1,455
|
1,455
|
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
1,423
|
1,523
|
|
86140
|
C-REACTIVE PROTEIN |
1,008
|
1,008
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
945
|
950
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
887
|
955
|
|
J1745
|
INFLIXIMAB NOT BIOSIMIL 10MG |
874
|
47,184
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
430
|
499
|
|
97530
|
THERAPEUTIC ACTIVITIES |
419
|
780
|
|
85652
|
RBC SED RATE AUTOMATED |
409
|
409
|
|
83993
|
ASSAY FOR CALPROTECTIN FECAL |
384
|
384
|
|
85027
|
COMPLETE CBC AUTOMATED |
374
|
374
|
|
Q5103
|
INJECTION, INFLECTRA |
333
|
15,505
|
|
97110
|
THERAPEUTIC EXERCISES |
327
|
469
|
|
80076
|
HEPATIC FUNCTION PANEL |
298
|
298
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
296
|
610
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
K51.919 related to the following DRG Codes:
385-387
|
